ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Hospitalist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,916Medicare Part D Prescriptions Filled, Including Refills
$553K Total Retail Price of All Prescriptions
458 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
7% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
SIMVASTATIN 402 384
OMEPRAZOLE 327 310
METFORMIN HCL 243 243
AMLODIPINE BESYLATE 221 203
CRESTOR 220 214
LEVOTHYROXINE SODIUM 212 184
CARVEDILOL 199 192
ATORVASTATIN CALCIUM 188 182
GLIMEPIRIDE 166 163
WARFARIN SODIUM 162 145
ZOLPIDEM TARTRATE 157 146
HYDROCODONE-ACETAMINOPHEN 141 103 S3
ENALAPRIL MALEATE 138 121
FUROSEMIDE 132 131
TRAMADOL HCL 129 125
LISINOPRIL 119 107
POTASSIUM CHLORIDE 118 118
SERTRALINE HCL 114 112
SYNTHROID 104 99
DONEPEZIL HCL 101 95
KLOR-CON 8 101 100
TRIAMTERENE-HCTZ 100 89
METOPROLOL SUCCINATE 97 91
METOPROLOL TARTRATE 97 87
PROPRANOLOL HCL 96 93
ALLOPURINOL 91 91
FLUOXETINE HCL 82 71
ESTRADIOL 79 79 R
TAMSULOSIN HCL 78 73
PANTOPRAZOLE SODIUM 77 75
FLUTICASONE PROPIONATE 76 73
DIGOXIN 69 69
MELOXICAM 65 64
BENICAR 64 61
DOXAZOSIN MESYLATE 63 56
ALENDRONATE SODIUM 61 59
LOSARTAN-HYDROCHLOROTHIAZIDE 57 57
GABAPENTIN 57 49
NAMENDA 56 55
ACTOS 55 55
BENAZEPRIL HCL 53 53
VERAPAMIL ER 53 42
CYMBALTA 53 48
DILTIAZEM 24HR CD 52 52
TRAZODONE HCL 52 52
DIOVAN HCT 52 52
CLOPIDOGREL 50 50
VYTORIN 50 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 27, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.